1. Feroze U, Martin D, Reina-Patton A, Kalantar-Zadeh K, Kopple JD. Mental health, depression, and anxiety in patients on maintenance dialysis. Iran J Kidney Dis 2010; 4(3): 173-180.
|
|
|
|
|
|
|
|
|
6. Tayyebi A, Babahaji M, Ebadi A, Eynollahi B. Study of the effect of Hatha Yoga exercises on stress, anxiety and depression among hemodialysis patients. International Journal of Critical Care Nursing 2011; 4(2): 67-72.
|
|
7. Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Association between depression and death in people with CKD: a meta‐analysis of cohort studies. American Journal of Kidney Diseases 2013;62(3):493‐505. https://doi.org/10.1053/j.ajkd.2013.02.369PMid:23623139
|
|
8. Ravaghi H, Behzadifar M, Behzadifar M, Taheri Mirghaed M, Aryankhesal A, Salemi M, Bragazzi NL. Prevalence of Depression in Hemodialysis Patients in Iran: a Systematic Review and Meta-analysis.Iran J Kidney Dis. 2017 Mar;11(2):90-98.
|
|
9. Biris A, Messinis L, Antoniadis G, Skarli V. Quality of life, Spouse Marital adjustment and Depression in a sample of End-Stage Renal Disease (ESRD) Patients in Greece. Hippokratia 2006; 6(1): 56-61.
|
|
10. Cohen SD, Kimmel PL. Nutritional status, psychological issues and survival in hemodialysis patients. Contrib Nephrol. 2007;155:1-17. https://doi.org/10.1159/000100952PMid:17369709
|
|
11. Walters BA, Hays RD, Spritzer KL, et al. Health-related quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation. Am J Kidney Dis. 2001;40:1185-1194. https://doi.org/10.1053/ajkd.2002.36879PMid:12460037
|
|
12. Lopes AA, Albert JM, Young EW, et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 2004;66:2047-2053. https://doi.org/10.1111/j.1523-1755.2004.00977.xPMid:15496178
|
|
13. Fischer MJ, Kimmel PL, Greene T, et al. Socioeconomic factors contribute to the depressive affect among African Americans with chronic kidney disease. Kidney Int. 2010;77:1010-1019. https://doi.org/10.1038/ki.2010.38PMid:20200503 PMCid:PMC3114445
|
|
14. Palmer SC1, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GF.Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis. Cochrane Database Syst Rev. 2016 May 23;(5):CD004541. https://doi.org/10.1002/14651858.CD004541.pub3
|
|
15. Laux G. Serotonin reuptake inhibitors: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline. InNeuroPsychopharmacotherapy 2021 (pp. 1-13). Cham: Springer International Publishing.2021;1-13 https://doi.org/10.1007/978-3-319-56015-1_413-1
|
|
16. Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurology international. 2021 Aug 5;13(3):387-401. https://doi.org/10.3390/neurolint13030038PMid:34449705 PMCid:PMC8395812
|
|
17. Chiappini S, Vickers-Smith R, Guirguis A, Corkery JM, Martinotti G, Schifano F. A focus on abuse/misuse and withdrawal issues with selective serotonin reuptake inhibitors (SSRIs): analysis of both the European EMA and the US FAERS pharmacovigilance databases. Pharmaceuticals. 2022 May 1;15(5):565. https://doi.org/10.3390/ph15050565PMid:35631391 PMCid:PMC9146999
|
|
18. Ghaffari Darab M, Hedayati A, Khorasani E, Bayati M, Keshavarz K. Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews. International journal of psychiatry in clinical practice. 2020 Oct 30;24(4):357-70. https://doi.org/10.1080/13651501.2020.1782433PMid:32667275
|
|
19. Dunham KE, Venton BJ. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila. Journal of neurochemistry. 2022 Sep;162(5):404-16. https://doi.org/10.1111/jnc.15658PMid:35736504 PMCid:PMC9427694
|
|
20. Boulenger, A. K. T. Huusom, I. Florea, T. Bækdal & M. Sarchiapone. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.2006;22(7). https://doi.org/10.1185/030079906X115513PMid:16834832
|
|
21. Bazire S. Psychotropic Drug Directory. The professionals' pocket handbook and aide memoire. Lloyd-Reinhold Communications LLP.2012:pp 89-90.
|
|
22. PSM Healthcare Limited. Citalopram tablets. New Zealand datasheet May 2015.www.medsafe.govt.nz/profs/datasheet/c/citalopramtab.pdf (Accessed 28-04-16).
|
|
23. Azorin JM1, Llorca PM, Despiegel N, Verpillat P. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Encephale. 2004 Mar-Apr;30(2):158-66. https://doi.org/10.1016/S0013-7006(04)95427-9PMid:15107719
|
|
24. Yevtushenko VY1, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Clin Ther. 2007 Nov;29(11):2319-32.30. https://doi.org/10.1016/j.clinthera.2007.11.014PMid:18158074
|
|
25. Yazici AE, Erdem P, Erdem A, Yazici K, Acar ST, Basterzi AD, et al. Efficacy and tolerability of escitalopram in depressed patients with end stage renal disease: an open placebo‐controlled study [Depresyonu olan son donem bobrek yetmezligi hastalarinda essitalopramin etkinligi ve tolerabilitesi: Bir acik lacebo kontrollu calisma]. Klinik Psikofarmakoloji Bulteni 2012;22(1):23‐30. https://doi.org/10.5455/bcp.20120215011558
|
|
26. Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736-45 https://doi.org/10.1093/ndt/gfs295PMid:22859791
|
|
27. Li H, Li T, Li G, Luo J. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials. Ann Clin Psychiatry. 2014 Nov;26(4):281-7.
|
|
28. Montgomery S, Hansen T, Kasper S. Efficacy of escitalopram compared to citalopram: a meta-analysis. International Journal of Neuropsychopharmacology. 2011 Mar 1;14(2):261-8. https://doi.org/10.1017/S146114571000115XPMid:20875220
|
|
29. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS spectrums. 2002 Apr;7(S1):40-4. https://doi.org/10.1017/S1092852900028595PMid:15131492
|
|
30. Sánchez C, Bøgesø KP, Ebert B, Reines EH, Braestrup C. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology. 2004 Jul; 174:163-76. https://doi.org/10.1007/s00213-004-1865-zPMid:15160261
|